Unknowns Remain Regarding Part D Senior Savings Model
Months after the Part D Senior Savings Model was unveiled, the Trump administration on May 26 held a press conference in the White House Rose Garden to share what reporters and industry observers hoped would be more information about the new benefit that will be available to seniors next year. But the few details that were disclosed regarding participation raised only more questions about the potential success of the model, experts suggest.
CMS on May 26 said 88 Part D sponsors have applied to offer enhanced plans with predictable cost sharing on insulin as part of the Part D Senior Savings Model. Introduced through the CMS Innovation Center in March, the five-year model is intended to lower out-of-pocket costs for diabetic seniors by featuring “predictable” copayments of no more than $35 for a broad set of insulins beginning in 2021 (RMA 3/19/20, p. 1).
Related Posts
Meet Our Reporters
-
Jill Drachenberg Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jill Drachenberg's Profile -
Lauren Flynn Kelly Executive Editor, AIS Health, and Managing Editor, Radar on Medicare Advantage
View Lauren Flynn Kelly's Profile -
Angela Maas Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access
View Angela Maas's Profile -
Leslie Small Managing Editor, Health Plan Weekly and Radar on Drug Benefits
View Leslie Small's Profile -
Tim Casey Reporter, Health Plan Weekly and Radar on Drug Benefits
View Tim Casey's Profile -
Carina Belles Reporter, Radar on Medicare Advantage and Spotlight on Market Access
View Carina Belles's Profile -
Jinghong Chen Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jinghong Chen's Profile
